- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02057588
Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms
April 5, 2022 updated by: Abbott Medical Devices
The objective of this study will be to evaluate the ability of IEGMs (Signal recorded from implanted pacing leads) and pseudo ECGs (derived from various IEGMs) to characterize various electrical conduction patterns.
Electroanatomic mapping data and 12 Lead ECG will also be collected to characterize electrical conduction patterns during standard electrophysiology exam.
Study Overview
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pessac, France, 33604
- CHU Haut Lévêque
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient with SJM CRM device implanted for more than 90 days
Exclusion Criteria:
- Suspicion of lead dislodgment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: LV Paced sites
LV pacing sites : Patients will be paced from various left ventricular origin, defined by their 3D localization.
|
Patient will be paced in VVI mode from Left ventricle specific position for a short period of time per position in order to cover spontaneous ventricular activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation of ventricular activation patterns determined by 12-lead ECG and device IEGMs-based method
Time Frame: Acute, intraoperative
|
Correlation coefficient between ventricular activation patterns determined by a traditional technique, 12-lead ECG based vs. device based IEGMs method.
|
Acute, intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ventricular activation origin location determined by IEGMs based method vs. by detailed mapping
Time Frame: Acute, intraoperative
|
Use of available IEGMs recorded on implanted device to discriminate specific VT origin and pattern and compare the results to the detailed mapping data
|
Acute, intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frederic Sacher, MD, CHU Bordeaux
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
January 31, 2014
First Submitted That Met QC Criteria
February 5, 2014
First Posted (Estimate)
February 7, 2014
Study Record Updates
Last Update Posted (Actual)
April 7, 2022
Last Update Submitted That Met QC Criteria
April 5, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-12-082-FR-HV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrythmia
-
Northwell HealthRecruitingVentricular ArrythmiaUnited States
-
Kasr El Aini HospitalCompleted
-
Assiut UniversityNot yet recruitingMigraine Seizures Encephalopathy | Arrythmia Congenital Heart Disease Cardiomyopathy
-
Shahid Beheshti University of Medical SciencesUnknownArrythmiaIran, Islamic Republic of
-
Medical College of WisconsinMedtronic; University of Wisconsin, MilwaukeeCompletedCardiovascular Diseases | Physical Activity | Arrythmia | PacemakerUnited States
-
Centro Hospitalar e Universitário de Coimbra, E...Not yet recruiting
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Ventricular ArrythmiaUnited States, Spain, Hong Kong, Singapore, Australia, Switzerland, France, India, Canada, Italy
-
Won Young KimRecruitingCardiac Arrest | Ventricular ArrythmiaKorea, Republic of
-
Ottawa Heart Institute Research CorporationCompleted
Clinical Trials on LV pacing site
-
Wake Forest University Health SciencesMedtronicTerminatedCongestive Heart Failure | LV DysfunctionUnited States
-
Seoul National University HospitalWithdrawnSick Sinus Syndrome | Complete AV BlockKorea, Republic of
-
National University Hospital, SingaporeUnknownTricuspid Valve Insufficiency | Sick Sinus SyndromeSingapore
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart Failure | Acute Myocardial Infarction | Cardiac Remodeling | Pacing TherapyUnited States, Denmark, Germany, France, Slovakia, Hungary, Saudi Arabia
-
Rigshospitalet, DenmarkImperial College Healthcare NHS TrustCompletedHeart Failure | Left Bundle-Branch BlockDenmark
-
Imperial College Healthcare NHS TrustRigshospitalet, DenmarkRecruiting
-
Charles University, Czech RepublicRecruitingVentricular Rhythm From Artificial PacingCzechia
-
Sheba Medical CenterUnknown
-
Medtronic Cardiac Rhythm and Heart FailureCompleted